Atherectomy Devices Market by Product Type, Distribution Channel, End User 2022-2027

Author: Elena Anderson

Marketing Manager

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Atherectomy Devices Market Research Report 2022-2027:

According to the latest report by IMARC Group, titled " Atherectomy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Foreca st 2022-2027

," the global atherectomy devices market size reached US$ 877 Million in 2021.

Atherectomy devices refer to minimally invasive (MI) instruments that are utilized for removing plaque and thrombus from diseased arteries. They are widely used for effectively treating both coronary and peripheral arterial diseases. Usually consisting of a rotating blade within a tubular catheter attached to a battery-operated motor, they commonly assist in re-establishing the blood flow in arteries by drilling, shaving, grinding, sanding and vaporizing plaque and calcifying lesions or excessive cellular materials.

As a result, these devices are extensively used for various applications across hospitals, clinics, surgical centers and ambulatory care centers.

Request for a PDF sample of this report:

https://www.imarcgroup.com/atherectomy-devices-market/requestsample

Global Atherectomy Devices Market Trends:

The market is primarily driven by the increasing incidences of peripheral artery diseases (PADs) and coronary artery diseases (CADs) on the global level, along with numerous other medical ailments, such as obesity, diabetes, cardiovascular disorders and atherosclerosis. Since atherectomy devices are widely used in the treatment of these medical conditions, this is providing a thrust to the market growth. Along with this, there has been a considerable rise in the geriatric population, who are more likely to suffer from numerous chronic conditions, which is acting as a major growth-inducing factor. The growing preference for minimally invasive (MI) surgeries among both the patients and the healthcare professionals due to the lesser risks and improved outcomes associated with these procedures is acting as another key factor contributing to the market growth.

Furthermore, the market is driven by the increasing usage of drug-coated balloons (DCB) in atherectomy procedures, along with the directional atherectomy with anti-restenosis therapy (DAART) to improve the patency in long lesions as well as lesions with severe calcifications. Some of the other factors contributing to the market growth include the rising number of strategic mergers and acquisitions (M&As) by players and the considerable improvements in the overall healthcare infrastructure.

Report Description Report Description and Highlights

Looking forward, the market is expected to grow at a CAGR of 5.2% during 2022-2027.

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Product:

• Directional Atherectomy Devices

• Orbital Atherectomy Devices

• Photo-Ablative Atherectomy Devices

• Rotational Atherectomy Devices

• Support Devices

Breakup by Application:

• Peripheral Vascular

• Cardiovascular

• Neurovascular

Breakup by End User:

• Hospitals

• Ambulatory Surgery Centers

• Research Laboratories and Academic Institutes

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

Competitive Landscape with Key Players:

• Abbott Laboratories

• Avinger

• B. Braun Melsungen AG

• Biomerics

• Biotronik

• Boston Scientific Corporation

• C.R. Bard (Becton, Dickinson and Company)

• Cardinal Health

• Koninklijke Philips N.V

• Medtronic

• Minnetronix Inc

• Straub Medical AG (Becton, Dickinson and Company)

• Terumo Corporation

1. What was the size of the global atherectomy devices market in 2021?

2. What is the expected growth rate of the global atherectomy devices market during 2022-2027?

3. What has been the impact of COVID-19 on the global atherectomy devices market?

4. What are the key factors driving the global atherectomy devices market?

5. What is the breakup of the global atherectomy devices market based on the product?

6. What is the breakup of the global atherectomy devices market based on the application?

7. What is the breakup of the global atherectomy devices market based on the end user?

8. What are the key regions in the global atherectomy devices market?

9. Who are the key players/companies in the global atherectomy devices market?

Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/atherectomy-devices-market/toc

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.